ストックスクリーナーアプリを入手
5.33
4.10%
0.21
プレマーケット:
5.30
-0.03
-0.56%
前日終値:
$5.12
開ける：
$5.16
24時間の取引高:
5.41M
Relative Volume:
1.34
時価総額：
$1.86B
収益：
$143.05M
当期純損益:
$-145.99M
株価収益率:
-12.45
EPS:
-0.4282
ネットキャッシュフロー:
$-134.06M
1週間 パフォーマンス:
+16.38%
1か月 パフォーマンス:
+23.38%
6か月 パフォーマンス:
-37.44%
1年 パフォーマンス:
+211.70%
1日の値動き範囲:
$5.105
$5.355
1週間の範囲:
$4.45
$5.355
52週間の値動き範囲:
$1.58
$9.75
Nuvation Bio Inc Stock (NUVB) Company Profile
Compare NUVB vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
5.33 | 1.79B | 143.05M | -145.99M | -134.06M | -0.4282 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-24 | 開始されました | Truist | Buy |
| 2025-11-19 | 開始されました | B. Riley Securities | Buy |
| 2025-09-30 | 開始されました | Jefferies | Buy |
| 2025-04-23 | 開始されました | Citizens JMP | Mkt Outperform |
| 2024-03-27 | アップグレード | Jefferies | Hold → Buy |
| 2024-03-26 | アップグレード | BTIG Research | Neutral → Buy |
| 2023-01-06 | ダウングレード | Jefferies | Buy → Hold |
| 2022-08-02 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2022-08-02 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-05-04 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-15 | 再開されました | BTIG Research | Buy |
| 2021-04-06 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-03-08 | 開始されました | BMO Capital Markets | Outperform |
| 2021-03-08 | 開始されました | BTIG Research | Buy |
| 2021-03-08 | 開始されました | Cowen | Outperform |
| 2021-03-08 | 開始されました | Jefferies | Buy |
| 2021-03-08 | 開始されました | Wedbush | Outperform |
すべてを表示
Nuvation Bio Inc (NUVB) 最新ニュース
Why Is Nuvation Bio Back On Penny Stock Watchlists? - Kalkine Media
Nuvation Bio: David Hung's Latest Venture Looks Undervalued At Current Level (NYSE:NUVB) - Seeking Alpha
Nuvation Bio director Robert Mashal buys $118,250 in stock - Investing.com
Nuvation Bio (NUVB) director’s trust buys 25,000 Class A shares - Stock Titan
Nuvation Bio stock reiterated at Market Outperform by Citizens - Investing.com India
Truist Financial Maintains Nuvation Bio(NUVB.US) With Buy Rating - Moomoo
Spotlight On Promising Penny Stocks For June 2026 - simplywall.st
RBC Capital reiterates Nuvation Bio stock rating on ROS1 space value By Investing.com - Investing.com Australia
RBC Capital reiterates Nuvation Bio stock rating on ROS1 space value - Investing.com Nigeria
Nuvation Bio: Buy The Ibtrozi Launch (Rating Upgrade) (NYSE:NUVB) - Seeking Alpha
Nuvation Bio (NUVB) Presents Outcomes from TRUST-II Study - Insider Monkey
Nuvation Bio’s cancer drug sNDA accepted by FDA for review - Investing.com
5 Best Penny Stocks with Huge Upside Potential - Insider Monkey
RBC Capital raises Nuvation Bio stock price target on glioma potential - Investing.com
NUVB Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
NUVB Stock Price, Quote & Chart | NUVATION BIO INC (NYSE:NUVB) - ChartMill
NUVB Q1 2026 Earnings: Modest EPS Beat Amid Continued Clinical ProgressEarnings Stability Report - newsline.com
Nuvation Bio Inc. Files Form 8-K with SEC Detailing Company Information and Annual Meeting Results - Minichart
Best Stocks Under $15 to Buy Right Now for High Growth Potential - Analytics Insight
Nuvation Bio execs to speak at Jefferies Healthcare Conference on June 3, 2026 - Pluang
Nuvation Bio to Present at the Jefferies Global Healthcare Conference - Investing News Network
Nuvation Bio (NUVB) shareholders elect directors, ratify KPMG and approve pay - Stock Titan
Nuvation Bio (NUVB) Reveals Promising Data from TRUST-II Study - GuruFocus
Nuvation Bio to Present New Quality-of-Life Data for IBTROZI® in Patients with ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2026 Annual Meeting - Investing News Network
Nuvation Bio presents quality of life data for IBTROZI at ASCO - Investing.com Nigeria
Nuvation Bio presents quality of life data for IBTROZI at ASCO By Investing.com - Investing.com South Africa
Nuvation Bio to Present New Quality-of-Life Data for IBTROZI® (Taletrectinib) in Patients with ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2026 Annual Meeting - PR Newswire
Nuvation Bio Inc. (NUVB) director awarded 76,923 stock options in corrected filing - Stock Titan
Nuvation Bio (NASDAQ: NUVB) awards 123,397 stock options to director - Stock Titan
Nuvation Bio (NUVB) director gets 123,397 stock options at $4.79 - Stock Titan
Director at Nuvation Bio (NASDAQ: NUVB) awarded 123,397 stock options - Stock Titan
Nuvation Bio (NUVB) director Cui receives 123,397 stock options expiring 2036 - Stock Titan
NUVB: IBTROZI's rapid first-line growth and robust pipeline drive strong outlook and financial stability - TradingView
NUVB: IBTROZI's strong first-line growth and pipeline progress drive optimism for future expansion - TradingView
Truist Securities Initiates Coverage of Nuvation Bio (NUVB) with Buy Recommendation - MSN
Nuvation Bio (NUVB) Collaborates with Thermo Fisher - Insider Monkey
Nuvation Bio rises as B. Riley starts at Buy on launch trajectory for lead drug - MSN
NUVB: All proposals passed, including director elections and auditor ratification, with strong quorum - TradingView
Nuvation bid to expand Ibtrozi label undergoes FDA review - MSN
NUVB: IBTROZI and safusidenib drive growth, with new DDC platform updates and strong financial runway - TradingView
Nuvation Bio Sharpens IBTROZI Focus With Thermo Fisher And FDA Steps - Yahoo Finance
Are options traders betting on a big move in Nuvation Bio stock? - MSN
Earnings call transcript: Nuvation Bio Q1 2026 revenue beats forecast, stock jumps - Investing.com Nigeria
David Abrams's Nuvation Bio Inc(NUVB) Holding History - GuruFocus
Nuvation Bio Inc. (NUVB) reports next week: Wall Street expects earnings growth - MSN
Nuvation Bio Completes IBTROZI Manufacturing Tech Transfer to Thermo Fisher - Contract Pharma
Nuvation Bio Collaborates With Thermo Fisher Scientific For Lung Cancer Treatment - Moomoo
Nuvation Bio stock (US55043Q1004): Manufacturing deal with Thermo Fisher for lung cancer drug - AD HOC NEWS
Nuvation Bio To Collaborate With Thermo Fisher Scientific For U.S.-Based Manufacturing Of Ibtrozi For Ros1-Positive Non-Small Cell Lung Cancer - TradingView
Nuvation Bio Inc (NUVB) 財務データ
収益
当期純利益
現金流量
EPS
2.60%
0.94%
大文字化:
|
ボリューム (24 時間):